Random triples
| Subject | Object |
|---|---|
| gptkb:Emmaus_Medical | FDA approval for Endari in 2017 |
| gptkb:Aurinia_Pharmaceuticals_Inc. | FDA approval for Lupkynis (2021) |
| gptkb:Sage_Therapeutics,_Inc. | FDA approval for Zurzuvae in 2023 |
| gptkb:Sage_Therapeutics,_Inc. | FDA approval for Zulresso in 2019 |